Platelet populations and priming in hematological diseases
- PMID: 28756877
- DOI: 10.1016/j.blre.2017.07.004
Platelet populations and priming in hematological diseases
Abstract
In healthy subjects and patients with hematological diseases, platelet populations can be distinguished with different response spectra in hemostatic and vascular processes. These populations partly overlap, and are less distinct than those of leukocytes. The platelet heterogeneity is linked to structural properties, and is enforced by inequalities in the environment. Contributing factors are variability between megakaryocytes, platelet ageing, and positive or negative priming of platelets during their time in circulation. Within a hemostatic plug or thrombus, platelet heterogeneity is enhanced by unequal exposure to agonists, with populations of contracted platelets in the thrombus core, discoid platelets at the thrombus surface, patches of ballooned and procoagulant platelets forming thrombin, and coated platelets binding fibrin. Several pathophysiological hematological conditions can positively or negatively prime the responsiveness of platelet populations. As a consequence, in vivo and in vitro markers of platelet activation can differ in thrombotic and hematological disorders.
Keywords: Activation markers; Platelet heterogeneity; Positive priming; Thrombus.
Copyright © 2017 Elsevier Ltd. All rights reserved.
Similar articles
-
Platelets and coagulation in thrombus formation: aberrations in the Scott syndrome.Thromb Res. 2016 May;141 Suppl 2:S12-6. doi: 10.1016/S0049-3848(16)30355-3. Thromb Res. 2016. PMID: 27207414 Review.
-
Platelet response heterogeneity in thrombus formation.Thromb Haemost. 2009 Dec;102(6):1149-56. doi: 10.1160/TH09-05-0289. Thromb Haemost. 2009. PMID: 19967145 Review.
-
Procoagulant platelets and the pathways leading to cell death.Semin Thromb Hemost. 2015 Jun;41(4):405-12. doi: 10.1055/s-0034-1544002. Epub 2015 Apr 16. Semin Thromb Hemost. 2015. PMID: 26035696 Review.
-
Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease.Cell Signal. 2014 Sep;26(9):2040-50. doi: 10.1016/j.cellsig.2014.05.019. Epub 2014 Jun 11. Cell Signal. 2014. PMID: 24928203
-
Superactivated platelets: thrombus regulators, thrombin generators, and potential clinical targets.Arterioscler Thromb Vasc Biol. 2013 Aug;33(8):1747-52. doi: 10.1161/ATVBAHA.113.301790. Arterioscler Thromb Vasc Biol. 2013. PMID: 23864724 Review.
Cited by
-
Clinical Protocol to Prevent Thrombogenic Effect of Liver-Derived Mesenchymal Cells for Cell-Based Therapies.Cells. 2019 Aug 7;8(8):846. doi: 10.3390/cells8080846. Cells. 2019. PMID: 31394759 Free PMC article.
-
Phosphoproteomic quantitation and causal analysis reveal pathways in GPVI/ITAM-mediated platelet activation programs.Blood. 2020 Nov 12;136(20):2346-2358. doi: 10.1182/blood.2020005496. Blood. 2020. PMID: 32640021 Free PMC article.
-
Multiparameter phenotyping of platelets and characterization of the effects of agonists using machine learning.Res Pract Thromb Haemost. 2024 Jul 22;8(5):102523. doi: 10.1016/j.rpth.2024.102523. eCollection 2024 Jul. Res Pract Thromb Haemost. 2024. PMID: 39252825 Free PMC article.
-
Platelet Membrane Receptor Proteolysis: Implications for Platelet Function.Front Cardiovasc Med. 2021 Jan 8;7:608391. doi: 10.3389/fcvm.2020.608391. eCollection 2020. Front Cardiovasc Med. 2021. PMID: 33490118 Free PMC article. Review.
-
The Association between the Platelet to White Blood Cell Ratio and Chronic Kidney Disease in an Aging Population: A Four-Year Follow-Up Study.J Clin Med. 2023 Nov 13;12(22):7073. doi: 10.3390/jcm12227073. J Clin Med. 2023. PMID: 38002686 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials